Avanos Medical Inc (NYSE:AVNS)
$ 15.2 -0.2 (-1.3%) Market Cap: 698.55 Mil Enterprise Value: 811.75 Mil PE Ratio: 44.71 PB Ratio: 0.57 GF Score: 63/100

Avanos Medical Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 03:30PM GMT
Release Date Price: $32.71 (-4.36%)
Sushil Bhandaru

Good morning, and thank you for joining us for today's session. My name is Sushil Bhandaru, and I'm an analyst in JPMorgan's Healthcare Investment Banking Group. And before we introduce you to our presenters today, we just want to call of note to the blue button at the bottom of the screen where you'll be able to submit any Q&A that you have during our session. With that, I'm pleased to introduce Joe Woody, CEO of Avanos; and Michael Greiner, SVP and CFO.

With that, I'll turn it over to them to talk to you a little bit about their story.

Joseph F. Woody
Avanos Medical, Inc. - CEO & Director

Thank you, Sushil. I'm very excited to update on Avanos, and I'm very -- thankful for those of you that are interested in the Avanos' story and our employees have been extremely resilient throughout the pandemic in setting the foundation really for our company going forward. As always, we'll be talking about forward-looking statements, risks like cost savings, reductions and raw material. The key is we'd like you to be able to be well aware of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot